-
1
-
-
0014976138
-
Serum cholesterol, lipoproteins, risk of coronary heart disease
-
Kannel, W.B.; Castelli, W.P.; Gordon, T.; McNamara, P.M. Serum cholesterol, lipoproteins, risk of coronary heart disease, Ann. Intern. Med. 1971, 74, 1-12.
-
(1971)
Ann. Intern. Med
, vol.74
, pp. 1-12
-
-
Kannel, W.B.1
Castelli, W.P.2
Gordon, T.3
McNamara, P.M.4
-
2
-
-
0032510662
-
Primary prevention of coronary heart disease
-
Grundi, S.M.; Balady, G.J.; Criqui, M.H.; Fletcher, G. Primary prevention of coronary heart disease: Guidance from framingham. Circulation. 1998, 97, 1876-1887.
-
(1998)
Guidance From Framingham. Circulation
, vol.97
, pp. 1876-1887
-
-
Grundi, S.M.1
Balady, G.J.2
Criqui, M.H.3
Fletcher, G.4
-
3
-
-
2342529102
-
Lipid lowering activity of drugs affecting cholesterol absorption
-
Norata, G.D.; Catapano, A.L. Lipid lowering activity of drugs affecting cholesterol absorption. Nutr. Metab. Cardiovasc. Dis. 2004, 14, 42-51.
-
(2004)
Nutr. Metab. Cardiovasc. Dis
, vol.14
, pp. 42-51
-
-
Norata, G.D.1
Catapano, A.L.2
-
4
-
-
0031715094
-
The pathophysiology of atherosclerosis
-
Mitchell, M.E., Sidawy, A.N. The pathophysiology of atherosclerosis. Semin Vasc Surg. 1998, 11, 134-141.
-
(1998)
Semin Vasc Surg
, vol.11
, pp. 134-141
-
-
Mitchell, M.E.1
Sidawy, A.N.2
-
5
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
Shepherd, J.; Cobbe, S.M.; Ford, I.; Isles, C.G.; Lorimer, A.R.; MacFarlane, P.W.; McKillop, J.H.; Packard, C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 1995, 333, 1301-1307.
-
(1995)
N. Engl. J. Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
Macfarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
6
-
-
0034723758
-
The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
-
Pearson, A.T.; Laurora, I.; Chu, H.; Kafonek, S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch. Intern. Med. 2000, 160, 459-467.
-
(2000)
Arch. Intern. Med
, vol.160
, pp. 459-467
-
-
Pearson, A.T.1
Laurora, I.2
Chu, H.3
Kafonek, S.4
-
7
-
-
0032032592
-
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia
-
Jones, P.; Kafonek, S.; Laurora, I.; Hunninghake, D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia. Am. J. Cardiol. 1998, 81, 582-587.
-
(1998)
Am. J. Cardiol
, vol.81
, pp. 582-587
-
-
Jones, P.1
Kafonek, S.2
Laurora, I.3
Hunninghake, D.4
-
8
-
-
0041706236
-
Metabolic effects of plant sterols and stanols
-
Jong, de A.; Plat, J.; Mensink, R.P. Metabolic effects of plant sterols and stanols. J. Nutr. Biochem. 2003, 14, 362-369.
-
(2003)
J. Nutr. Biochem
, vol.14
, pp. 362-369
-
-
Jong, D.A.1
Plat, J.2
Mensink, R.P.3
-
9
-
-
0142183214
-
Acyl coenzyme A: Cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis
-
Miyazaki, M.; Sakai, Y.; Sakamoto, S.H. Acyl coenzyme A: cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis. Curr. Opin. Investig. Drugs. 2003, 4, 1095-1099.
-
(2003)
Curr. Opin. Investig. Drugs
, vol.4
, pp. 1095-1099
-
-
Miyazaki, M.1
Sakai, Y.2
Sakamoto, S.H.3
-
10
-
-
0346367064
-
New lipid-lowering agents
-
Wierzbicki, S. New lipid-lowering agents. Exp. Opin. Emerg. Drugs. 2003, 8, 365-376.
-
(2003)
Exp. Opin. Emerg. Drugs
, vol.8
, pp. 365-376
-
-
Wierzbicki, S.1
-
11
-
-
10744221008
-
Niemann- Pick C1 Like 1 protein is critical for intestinal cholesterol absorption
-
Altmann, W.S.; Davis, R.H. Jr.; Zhu, J.L.; Yao, X.; Hoos, M.L.; Tetzloff, G.; Iyer, P.S.; Maguire, M.; Golovko, A.; Zeng, M.; Wang, L.; Murgolo, N.; Graziano, P.M.; Niemann, Y.P. Niemann- Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004, 303, 1201-1204.
-
(2004)
Science
, vol.303
, pp. 1201-1204
-
-
Altmann, W.S.1
Davis Jr., R.H.2
Zhu, J.L.3
Yao, X.4
Hoos, M.L.5
Tetzloff, G.6
Iyer, P.S.7
Maguire, M.8
Golovko, A.9
Zeng, M.10
Wang, L.11
Murgolo, N.12
Graziano, P.M.13
Niemann, Y.P.14
-
12
-
-
0018616737
-
Esterification of cholesterol in human small intestine: The importance of Acyl CoA: Cholesterol acyltransferase
-
Norum, K.R.; Lilljeqvist, A.C.; Helgerud, P.; Normann E.R.; Mo, A.; Selbekk, B. Esterification of cholesterol in human small intestine: the importance of Acyl CoA: cholesterol acyltransferase. Eur. J. Clin. Invest. 1979, 9, 55-62.
-
(1979)
Eur. J. Clin. Invest
, vol.9
, pp. 55-62
-
-
Norum, K.R.1
Lilljeqvist, A.C.2
Helgerud, P.3
Normann, E.R.4
Mo, A.5
Selbekk, B.6
-
13
-
-
0021043541
-
Role of Acyl CoA: Cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in rabbit
-
Heider, J.G.; Pickens, C.E.; Kelly, L.A. Role of Acyl CoA: cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in rabbit. J. Lipid. Res. 1983, 24, 1127-1134.
-
(1983)
J. Lipid. Res
, vol.24
, pp. 1127-1134
-
-
Heider, J.G.1
Pickens, C.E.2
Kelly, L.A.3
-
14
-
-
0021237202
-
Intestinal cholesterol esterase: Intracellular enzyme or contamination of cytosol by pancreatic enzymes
-
Field, F.J. Intestinal cholesterol esterase: intracellular enzyme or contamination of cytosol by pancreatic enzymes. J. Lipid. Res., 1984, 25, 389-399.
-
(1984)
J. Lipid. Res
, vol.25
, pp. 389-399
-
-
Field, F.J.1
-
15
-
-
0022256566
-
Role of acyl Co-A: Cholesterol acyl transferase in cellular cholesterol metabolism
-
Suckling, K.E.; Stange, E F. Role of acyl Co-A: cholesterol acyl transferase in cellular cholesterol metabolism. J. Lipid Res. 1985, 26, 647-671.
-
(1985)
J. Lipid Res
, vol.26
, pp. 647-671
-
-
Suckling, K.E.1
Stange, E.F.2
-
16
-
-
0019430455
-
Acyl-CoA: Cholesterol acyltransferase in human small intestine: Its activity and some properties of enzymic action
-
Helgerud, P.; Saarem, K.; Nonm, K.R. Acyl-CoA: cholesterol acyltransferase in human small intestine: its activity and some properties of enzymic action. J. Lipid. Res. 1981, 22, 271-277.
-
(1981)
J. Lipid. Res
, vol.22
, pp. 271-277
-
-
Helgerud, P.1
Saarem, K.2
Nonm, K.R.3
-
17
-
-
84892439816
-
-
Health.allrefer.com/pictures-images/enlarged-view-ofatherosclerosis.html.
-
-
-
-
18
-
-
63349109364
-
Acyl coenzymeA: Cholesterol acyltransferase family
-
Liu, Y.; Guo, Z. Acyl coenzymeA: cholesterol acyltransferase family. Front. Biol. China. 2009, 4, 129-136.
-
(2009)
Front. Biol. China
, vol.4
, pp. 129-136
-
-
Liu, Y.1
Guo, Z.2
-
19
-
-
51449089950
-
Identification of putative active site residues of ACAT enzymes
-
Das, A.; Davis, M.A.; Rudel, L.L. Identification of putative active site residues of ACAT enzymes. J. Lipid. Res. 2008. 49, 1770-1781.
-
(2008)
J. Lipid. Res
, vol.49
, pp. 1770-1781
-
-
Das, A.1
Davis, M.A.2
Rudel, L.L.3
-
21
-
-
0025756150
-
Therapeutic potential of ACAT inhibitors as lipid lowering and antiatherosclerotic agents
-
Sliskovic, D.R.; White, A.D. Therapeutic potential of ACAT inhibitors as lipid lowering and antiatherosclerotic agents. Trends. Pharmacol. Sci. 1991, 12, 194-199.
-
(1991)
Trends. Pharmacol. Sci
, vol.12
, pp. 194-199
-
-
Sliskovic, D.R.1
White, A.D.2
-
22
-
-
0023882098
-
Isolation and characterization of Chinese hamster ovary cell mutants deficient an acyl-coenzyme A: Cholesterol acyltransferase activity
-
Cadigan, K.M.; Heider, J.G.; Chang, T.Y. Isolation and characterization of Chinese hamster ovary cell mutants deficient an acyl-coenzyme A: cholesterol acyltransferase activity. J. Biol. Chem., 1988, 263, 274-282.
-
(1988)
J. Biol. Chem
, vol.263
, pp. 274-282
-
-
Cadigan, K.M.1
Heider, J.G.2
Chang, T.Y.3
-
23
-
-
0027527733
-
Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells
-
Chang, C.C.; Huh, H.Y.; Cadigan, K.M., Chang, T.Y. Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 1993, 268, 20747-20755.
-
(1993)
J. Biol. Chem
, vol.268
, pp. 20747-20755
-
-
Chang, C.C.1
Huh, H.Y.2
Cadigan, K.M.3
Chang, T.Y.4
-
24
-
-
15444348784
-
ACAT-2, a second mammalian ACAT: Its cloning, expression and characterization
-
Cases, S.; Novak, S.; Zheng, Y.W.; Myers, H.M.; Lear, S.K.; Sande, E.; Welch, C.B.; Lusis, A.J.; Spencer, T.A.; Krause, B.R.; Erickson, S.K.; Farese, R.V. ACAT-2, a second mammalian ACAT: its cloning, expression and characterization. J. Biol. Chem. 1998, 273, 26755-26764.
-
(1998)
J. Biol. Chem
, vol.273
, pp. 26755-26764
-
-
Cases, S.1
Novak, S.2
Zheng, Y.W.3
Myers, H.M.4
Lear, S.K.5
Sande, E.6
Welch, C.B.7
Lusis, A.J.8
Spencer, T.A.9
Krause, B.R.10
Erickson, S.K.11
Farese, R.V.12
-
25
-
-
0032500649
-
Identification of a form of ACAT specific to liver and intestine in nonhuman primates
-
Anderson, R.A.; Joyce, C.; Davis, M.; Reagan, J.W.; Clark, M.; Shelness, G.S.; Rudell, L.L. Identification of a form of ACAT specific to liver and intestine in nonhuman primates. J. Biol. Chem. 1998, 273, 26747-26754.
-
(1998)
J. Biol. Chem
, vol.273
, pp. 26747-26754
-
-
Anderson, R.A.1
Joyce, C.2
Davis, M.3
Reagan, J.W.4
Clark, M.5
Shelness, G.S.6
Rudell, L.L.7
-
26
-
-
0033876174
-
Localization of human ACAT-1 in macrophages and in various tissue
-
Shakashita, N.; Miyazaki, A.; Takeya, M.; Horiuchi, S.; Chang, C.C.; Chang, T.Y.; Takahashi, K. Localization of human ACAT-1 in macrophages and in various tissue. Am. J. Pathol. 2000, 156(1), 227-236.
-
(2000)
Am. J. Pathol
, vol.156
, Issue.1
, pp. 227-236
-
-
Shakashita, N.1
Miyazaki, A.2
Takeya, M.3
Horiuchi, S.4
Chang, C.C.5
Chang, T.Y.6
Takahashi, K.7
-
27
-
-
0034623070
-
Immunological quatification and localization of ACAT-1and ACAT-2 in human liver and small intestine
-
Chang, C.C.; Sakashita, N.; Ornvold, K.; Lee, E.; Chang, E.T.; Dong, R.; Lin, S.; Lee, C.Y.; Strom, S.C.; Kashyap, R.; Fung, J.J. Immunological quatification and localization of ACAT-1and ACAT-2 in human liver and small intestine. J. Biol. Chem. 2000, 275(36), 28083-28092.
-
(2000)
J. Biol. Chem
, vol.275
, Issue.36
, pp. 28083-28092
-
-
Chang, C.C.1
Sakashita, N.2
Ornvold, K.3
Lee, E.4
Chang, E.T.5
Dong, R.6
Lin, S.7
Lee, C.Y.8
Strom, S.C.9
Kashyap, R.10
Fung, J.J.11
-
28
-
-
20844451381
-
ACAT-2 is localized to hepatocyte and is the major cholesterol esterifying enzyme in human liver
-
Parini, P.; Davis, M.; Lada, A.T.; Erickson, S.K.; Wright, T.L.; Gustafsson, U.; Sahlin, S.; Eriksson, M.; Angelin, B.; Tomoda, H.; Omura, S.; Willingham, M.C. ACAT-2 is localized to hepatocyte and is the major cholesterol esterifying enzyme in human liver. Circulation. 2004, 110, 2017-2023.
-
(2004)
Circulation
, vol.110
, pp. 2017-2023
-
-
Parini, P.1
Davis, M.2
Lada, A.T.3
Erickson, S.K.4
Wright, T.L.5
Gustafsson, U.6
Sahlin, S.7
Eriksson, M.8
Angelin, B.9
Tomoda, H.10
Omura, S.11
Willingham, M.C.12
-
29
-
-
0347334429
-
Obesity, adiponectin and vascular inflammatory disease
-
Ouchi, N.; Kihara, K.; Funahashi, T.; Matsuzawa, Y.; Walsh, K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14, 561-568.
-
(2003)
Curr. Opin. Lipidol
, vol.14
, pp. 561-568
-
-
Ouchi, N.1
Kihara, K.2
Funahashi, T.3
Matsuzawa, Y.4
Walsh, K.5
-
30
-
-
1842689809
-
Adiponectin down regulates ACAT-1 in cultured human monocytederived macrophages
-
Furukawa, K.; Hori, M.; Ouchi, N.; Kihara, S.; Funahashi, T.; Matsuzawa, Y.; Miyazaki, A.; Nakayama S.; Horiuchi, S. Adiponectin down regulates ACAT-1 in cultured human monocytederived macrophages. Biochem. Biophys. Res. Commun. 2004, 317, 831-836.
-
(2004)
Biochem. Biophys. Res. Commun
, vol.317
, pp. 831-836
-
-
Furukawa, K.1
Hori, M.2
Ouchi, N.3
Kihara, S.4
Funahashi, T.5
Matsuzawa, Y.6
Miyazaki, A.7
Nakayama, S.8
Horiuchi, S.9
-
31
-
-
3342943329
-
ACAT inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1 and low-density lipoprotein receptor deficiencies in nephritic syndrome
-
Vaziri, N.D.; Liang, K.H. ACAT inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1 and low-density lipoprotein receptor deficiencies in nephritic syndrome. Circulation. 2004, 110, 419-425.
-
(2004)
Circulation
, vol.110
, pp. 419-425
-
-
Vaziri, N.D.1
Liang, K.H.2
-
32
-
-
0033551669
-
Human ACAT-1 in the endoplasmic reticulum contains seven transmembrane domains
-
Lin, S.; Cheng, D.; Liu, M.S.; Chen, J.; Cheng, T.Y. Human ACAT-1 in the endoplasmic reticulum contains seven transmembrane domains. J. Biol. Chem., 1999, 274, 23276-23285.
-
(1999)
J. Biol. Chem
, vol.274
, pp. 23276-23285
-
-
Lin, S.1
Cheng, D.2
Liu, M.S.3
Chen, J.4
Cheng, T.Y.5
-
33
-
-
0033739779
-
ACAT-1 and ACAT-2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane
-
Joyce, C.W.; Shelness, G.S.; Davis, M.A.; Lee, R.G.; Skinner, K.; Anderson, R.A.; Rudel, L.L. ACAT-1 and ACAT-2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol. Biol. Cell. 2000, 11, 3675-3687.
-
(2000)
Mol. Biol. Cell
, vol.11
, pp. 3675-3687
-
-
Joyce, C.W.1
Shelness, G.S.2
Davis, M.A.3
Lee, R.G.4
Skinner, K.5
Anderson, R.A.6
Rudel, L.L.7
-
34
-
-
27844475676
-
The active site His-460 of human Acyl-coenzyme A: Cholesterol acyltransferase 1 residues in a hitherto undisclosed tranmembrane domain
-
Guo, Z.Y.; Lin, S.; Heinen, J.A.; Chang, C.C.; Chang, T. The active site His-460 of human Acyl-coenzyme A: cholesterol acyltransferase 1 residues in a hitherto undisclosed tranmembrane domain. J. Biol. Chem. 2005, 280, 37814-37826.
-
(2005)
J. Biol. Chem
, vol.280
, pp. 37814-37826
-
-
Guo, Z.Y.1
Lin, S.2
Heinen, J.A.3
Chang, C.C.4
Chang, T.5
-
35
-
-
0037632868
-
Human acyl-coenzyme A: Cholesterase expressed in Chinese hamster ovary cells: Membrane topology and active site location Mol
-
Lin, S.; Lu, X.; Chang, C.C.; Chang, T.Y. Human acyl-coenzyme A: cholesterase expressed in Chinese hamster ovary cells: membrane topology and active site location Mol. Biol. Cell., 2003, 14, 2447-2460.
-
(2003)
Biol. Cell
, vol.14
, pp. 2447-2460
-
-
Lin, S.1
Lu, X.2
Chang, C.C.3
Chang, T.Y.4
-
36
-
-
0025756150
-
Therapeutic potential of ACAT inhibitors as lipid lowring and antiatherosclerotic agents
-
Sliskovic, D.R.; White, A.D. Therapeutic potential of ACAT inhibitors as lipid lowring and antiatherosclerotic agents. Trends in Pharmacol. Sci., 1991, 12, 194-199.
-
(1991)
Trends In Pharmacol. Sci
, vol.12
, pp. 194-199
-
-
Sliskovic, D.R.1
White, A.D.2
-
37
-
-
0034520194
-
Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, Kidney and adrenal of nonhuman primates
-
Lee, R.G.; Willingham, M.C.; Davis, M.A.; Skinner, K.A.; Rudel, L.L. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, Kidney and adrenal of nonhuman primates. J. Lipid. Res. 2000. 41. 1991-2001.
-
(2000)
J. Lipid. Res
, vol.41
, pp. 1991-2001
-
-
Lee, R.G.1
Willingham, M.C.2
Davis, M.A.3
Skinner, K.A.4
Rudel, L.L.5
-
38
-
-
0011452376
-
Factors facilitating cholesterol absorption from the intestine via lymphatic pathways
-
Vahouny, G.; Falwal, V.; Treadwell, C.R. Factors facilitating cholesterol absorption from the intestine via lymphatic pathways. Am. J. Physiol. 1957, 188, 342-346.
-
(1957)
Am. J. Physiol
, vol.188
, pp. 342-346
-
-
Vahouny, G.1
Falwal, V.2
Treadwell, C.R.3
-
39
-
-
0023154980
-
Normal cholesterol absorption in rats deficient in intestinal ACAT activity
-
Gallo, L.L.; Wadsworth, J.A.; Vahouny, G.V. Normal cholesterol absorption in rats deficient in intestinal ACAT activity. J. Lipid Res. 1987, 28, 381.
-
(1987)
J. Lipid Res
, vol.28
, pp. 381
-
-
Gallo, L.L.1
Wadsworth, J.A.2
Vahouny, G.V.3
-
40
-
-
0024389312
-
CL 277,082: A novel inhibitor of ACAT-catalysed cholesterol esterificationand cholesterol absorption
-
Largis, E.F.; Wang, C.H.; Davries, V.G.; Schaffer, S.A. CL 277,082: A novel inhibitor of ACAT-catalysed cholesterol esterificationand cholesterol absorption. J. Lipid. Res. 1989, 30, 681-690.
-
(1989)
J. Lipid. Res
, vol.30
, pp. 681-690
-
-
Largis, E.F.1
Wang, C.H.2
Davries, V.G.3
Schaffer, S.A.4
-
41
-
-
0017670576
-
Studies of the mechanism of augmented synthesis of cholesterol ester in atherosclerotic rabbit aortic microsomes
-
Hashimoto, S.; Dayton, S. Studies of the mechanism of augmented synthesis of cholesterol ester in atherosclerotic rabbit aortic microsomes. Athrosclerosis. 1977, 28, 447-452.
-
(1977)
Athrosclerosis
, vol.28
, pp. 447-452
-
-
Hashimoto, S.1
Dayton, S.2
-
42
-
-
0031668254
-
Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes macrophages
-
Miyazaki, A.; Sakashita, N.; Lee, O.; Takahashi, K.; Horiuchi, S.; Hakamata, H.; Morgnelli, P.M.; Chang, C.C.Y.; Chang, T.Y. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes macrophages. Arterioscl. Thromb. Vasc. Biol. 1998, 18, 1568-1574.
-
(1998)
Arterioscl. Thromb. Vasc. Biol
, vol.18
, pp. 1568-1574
-
-
Miyazaki, A.1
Sakashita, N.2
Lee, O.3
Takahashi, K.4
Horiuchi, S.5
Hakamata, H.6
Morgnelli, P.M.7
Chang, C.C.Y.8
Chang, T.Y.9
-
43
-
-
0025667289
-
Regulation of apo B secretion from HepG2 cells: Evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge
-
Cianflone, K M.; Yasruel, Z.; Rodriguez, M.A.; Sniderman, A.D. Regulation of apo B secretion from HepG2 cells: Evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 1990, 31, 2045-2055.
-
(1990)
J. Lipid Res
, vol.31
, pp. 2045-2055
-
-
Cianflone, K.M.1
Yasruel, Z.2
Rodriguez, M.A.3
Sniderman, A.D.4
-
44
-
-
0027405261
-
Enzymatic determination of triglyceride, free cholesterol and total cholesterol in tissue extracts
-
Carr, T.P.; Rudell, L.L. Enzymatic determination of triglyceride, free cholesterol and total cholesterol in tissue extracts. Clin. Biochem. 1993, 26. 39-42.
-
(1993)
Clin. Biochem
, vol.26
, pp. 39-42
-
-
Carr, T.P.1
Rudell, L.L.2
-
45
-
-
0023225958
-
Inhibition of total cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblast
-
Middleton, B. Inhibition of total cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblast. Biochem. Biophys. Res. Commun. 1987, 145, 350-356.
-
(1987)
Biochem. Biophys. Res. Commun
, vol.145
, pp. 350-356
-
-
Middleton, B.1
-
46
-
-
0021320894
-
Selective inhibition of ACAT by compound 58-035
-
Ross, A.C.; Go, K.J.; Heider, J.G. Selective inhibition of ACAT by compound 58-035. J. Biol. Chem. 1984, 259, 815-819.
-
(1984)
J. Biol. Chem
, vol.259
, pp. 815-819
-
-
Ross, A.C.1
Go, K.J.2
Heider, J.G.3
-
47
-
-
0022518433
-
Hepatic ACAT. Development of a standard assay and determination in patients with cholesterol gallstones
-
Smith, J.L.; DeJersey, J.; Pillay, S.P.; Hardie, J.R. Hepatic ACAT. Development of a standard assay and determination in patients with cholesterol gallstones. Clin. Chim. Acta. 1986, 158, 271-282.
-
(1986)
Clin. Chim. Acta
, vol.158
, pp. 271-282
-
-
Smith, J.L.1
Dejersey, J.2
Pillay, S.P.3
Hardie, J.R.4
-
48
-
-
0020972414
-
Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
-
Brown, M.S.; Goldstein, J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Res. Biochem. 1983, 52, 223-261.
-
(1983)
Annu. Res. Biochem
, vol.52
, pp. 223-261
-
-
Brown, M.S.1
Goldstein, J.L.2
-
49
-
-
0024603895
-
Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogeniciy
-
Steinberg, D.; Parthasarathy, S.; Carew, T.E.; Khoo, J.C.; Witzum, J.L. Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogeniciy. New Engl. J. Med. 1989, 320, 915-924.
-
(1989)
New Engl. J. Med
, vol.320
, pp. 915-924
-
-
Steinberg, D.1
Parthasarathy, S.2
Carew, T.E.3
Khoo, J.C.4
Witzum, J.L.5
-
50
-
-
0027527733
-
Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells
-
Chang, C.C.; Huh, H.Y.; Cadigan, K.M.; Chang, T.Y. Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 1993, 268, 20747-20755.
-
(1993)
Biol. Chem
, vol.268
, pp. 20747-20755
-
-
Chang, C.C.1
Huh, H.Y.2
Cadigan, K.M.3
Chang, T.Y.4
-
51
-
-
20144365248
-
ACAT2 is a target for treatment of coronary heart disease associated hypercholesterolemia
-
Rudel, L.L.; Lee, R.G.; Parini, P. ACAT2 is a target for treatment of coronary heart disease associated hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2005. 25. 1112-1118.
-
(2005)
Arterioscler. Thromb. Vasc. Biol
, vol.25
, pp. 1112-1118
-
-
Rudel, L.L.1
Lee, R.G.2
Parini, P.3
-
52
-
-
0023712067
-
Cholesterol lowering effect of N-(alphamethylbenzyl)linoleamide (melinamide) in cholesterol-fed diabetic rats
-
Matsubara, K.; Matsuzawa, Y.; Jiao, S.; Kihara, S.; Takama, T.; Nakamura, T.; Tokunaga, K.; Kubo, M.; Tarui, S. Cholesterol lowering effect of N-(alphamethylbenzyl)linoleamide (melinamide) in cholesterol-fed diabetic rats. Atherosclerosis. 1988, 72, 199-204.
-
(1988)
Atherosclerosis
, vol.72
, pp. 199-204
-
-
Matsubara, K.1
Matsuzawa, Y.2
Jiao, S.3
Kihara, S.4
Takama, T.5
Nakamura, T.6
Tokunaga, K.7
Kubo, M.8
Tarui, S.9
-
53
-
-
0023028820
-
Mechanism of the inhibition of cholesterol absorption by DLmelinamide: Inhibition of cholesterol esterification. Jpn
-
Natori, K.; Okazaki, Y.; Nakajima, T.; Hirohashi, T.; Aono, S. Mechanism of the inhibition of cholesterol absorption by DLmelinamide: inhibition of cholesterol esterification. Jpn. J. Pharmacol. 1986, 42, 517-523.
-
(1986)
J. Pharmacol
, vol.42
, pp. 517-523
-
-
Natori, K.1
Okazaki, Y.2
Nakajima, T.3
Hirohashi, T.4
Aono, S.5
-
54
-
-
0026668238
-
Inhibitor of Acyl-CoA:Cholesterol Acyltransferase. Identification and Structure-Activity Relationships of a novel series of fatty acid anilide hypocholesterolemic agents
-
Roth, B.D.; Blankley, C.J.; Hoefle, M.L.; Holme, A.; Roark, H.; Trivedi, B.K.; Essenburg, A. D.; Kieft, K.A.; Krause, B.R.; Stanfield, R.L. Inhibitor of Acyl-CoA:Cholesterol Acyltransferase. Identification and Structure-Activity Relationships of a novel series of fatty acid anilide hypocholesterolemic agents. J. Med. Chem. 1992, 35, 1609-1617.
-
(1992)
J. Med. Chem
, vol.35
, pp. 1609-1617
-
-
Roth, B.D.1
Blankley, C.J.2
Hoefle, M.L.3
Holme, A.4
Roark, H.5
Trivedi, B.K.6
Essenburg, A.D.7
Kieft, K.A.8
Krause, B.R.9
Stanfield, R.L.10
-
55
-
-
0026347265
-
Comparision of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological and morphometric evaluation
-
Bocan, T.M.A.; Bak Muller, S.; Uhlehndorf, P.D.; Newton, R.S.; Krause, B.R. Comparision of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological and morphometric evaluation. Arteri. Throm. 1991, 11, 1830-1843.
-
(1991)
Arteri. Throm
, vol.11
, pp. 1830-1843
-
-
Bocan, T.M.A.1
Bak, M.S.2
Uhlehndorf, P.D.3
Newton, R.S.4
Krause, B.R.5
-
56
-
-
0028244454
-
Potent, selective and systemically available inhibitors of Acyl-Coenzyme A:Cholesterol acyl transferase
-
Mc Carthy, P.A.; Hamanaka, E.S.; Marzetta, C.A.; Bamberger, M.J.; Gaynor, B.J.; Chang, G.; Kelly, S.E.; Inskeep, P.B.; Mayne, J.T.; Beyer, T.A. Potent, selective and systemically available inhibitors of Acyl-Coenzyme A:cholesterol acyl transferase. J. Med.Chem. 1994, 37, 1252-1255.
-
(1994)
J. Med.Chem
, vol.37
, pp. 1252-1255
-
-
McCarthy, P.A.1
Hamanaka, E.S.2
Marzetta, C.A.3
Bamberger, M.J.4
Gaynor, B.J.5
Chang, G.6
Kelly, S.E.7
Inskeep, P.B.8
Mayne, J.T.9
Beyer, T.A.10
-
57
-
-
0028889942
-
ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys
-
Carr, T.P.; Hamilton, R.L. jr.; Rudel, L.L. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. Lipid Research, 1995, 36, 25-36.
-
(1995)
Lipid Research
, vol.36
, pp. 25-36
-
-
Carr, T.P.1
Hamilton Jr., R.L.2
Rudel, L.L.3
-
58
-
-
0027515298
-
Inhibitors of Acyl coA:Cholesterol acyltransferase. 5. Identification and SARs of novel β-ketoamides as hypocholesterolemic agents
-
Augelli-Szafran, C.E.; Blankley, C.J.; Roth, B.D.; Trivedi, B.K.; Bousley, R. F.; Essenburg, A.D.; Hamelehle, K.L.; Krause, B.R.; Stanfield, R.L. Inhibitors of Acyl coA:cholesterol acyltransferase. 5. Identification and SARs of novel β-ketoamides as hypocholesterolemic agents. J. Med. Chem., 1993, 36, 2943-2949.
-
(1993)
J. Med. Chem
, vol.36
, pp. 2943-2949
-
-
Augelli-Szafran, C.E.1
Blankley, C.J.2
Roth, B.D.3
Trivedi, B.K.4
Bousley, R.F.5
Essenburg, A.D.6
Hamelehle, K.L.7
Krause, B.R.8
Stanfield, R.L.9
-
59
-
-
0028348156
-
Imidazolidinones and pyrazolones as novel ACAT inhibitors: Chemistry and biological activity
-
Augelli-Szafran, C.E.; Roth B.D.; Essenburg, A.D.; Hamelehle, K.L., Krause, B.R.; Stanfield, R.L. Imidazolidinones and pyrazolones as novel ACAT inhibitors: chemistry and biological activity. Bioorg. Med. Chem. Lett. 1994, 4, 1095-1100.
-
(1994)
Bioorg. Med. Chem. Lett
, vol.4
, pp. 1095-1100
-
-
Augelli-Szafran, C.E.1
Roth, B.D.2
Essenburg, A.D.3
Hamelehle, K.L.4
Krause, B.R.5
Stanfield, R.L.6
-
60
-
-
0002624168
-
ACAT inhibitors: Potential antiatherosclerotic agents
-
Sliscovic D.R.; Trivedi, B.K. ACAT inhibitors: potential antiatherosclerotic agents. Curr. Med. Chem. 1994, 1, 204-224.
-
(1994)
Curr. Med. Chem
, vol.1
, pp. 204-224
-
-
Sliscovic, D.R.1
Trivedi, B.K.2
-
61
-
-
84892446546
-
-
O'Brien, P.M.; Sliskovic, D.R.; Anderson, M.K.; Bousley, R.F.; Krause, B.R.; Stanfield, R.L. Inhibitors of
-
Inhibitors Of
-
-
O'Brien, P.M.1
Sliskovic, D.R.2
Anderson, M.K.3
Bousley, R.F.4
Krause, B.R.5
Stanfield, R.L.6
-
62
-
-
0028819250
-
ACAT as hypocholesterolemic agents. 12. Synthesis and biological activity of structurally novel tetrazole amide
-
ACAT as hypocholesterolemic agents. 12. Synthesis and biological activity of structurally novel tetrazole amide. Bioorg. Med. Chem. Lett. 1995, 5, 289-294.
-
(1995)
Bioorg. Med. Chem. Lett
, vol.5
, pp. 289-294
-
-
-
63
-
-
0028855474
-
Inhibitors of ACAT as hypocholesterolemic agents. 13. Design, synthesis and biological evaluation of tetrazole anilides as potent inhibitors of ACAT in vitro and hypocholesterolemic agents in vivo
-
O'Brien, P.M.; Sliskovic, D.R.; Anderson, M.K.; Bousley, R.F.; Krause, B.R.; Stanfield, R.L. Inhibitors of ACAT as hypocholesterolemic agents. 13. Design, synthesis and biological evaluation of tetrazole anilides as potent inhibitors of ACAT in vitro and hypocholesterolemic agents in vivo. Bioorg. Med. Chem. Lett. 1995, 5, 295-300.
-
(1995)
Bioorg. Med. Chem. Lett
, vol.5
, pp. 295-300
-
-
O'Brien, P.M.1
Sliskovic, D.R.2
Anderson, M.K.3
Bousley, R.F.4
Krause, B.R.5
Stanfield, R.L.6
-
64
-
-
0029898322
-
Inhibitors of ACAT. Synthesis and pharmacological activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6- trimethoxyphenyl)-2H-tetrazole-5-acetamide and structurally related tetrazole amide derivatives
-
O'Brien, P.M.; Sliskovic, D.R.; Picard, J.A.; Lee, H.T.; Purchase, C.F.; Roth, B.D.; White, A.D. Inhibitors of ACAT. Synthesis and pharmacological activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6- trimethoxyphenyl)-2H-tetrazole-5-acetamide and structurally related tetrazole amide derivatives. J. Med. Chem. 1996, 39, 2354-2366.
-
(1996)
J. Med. Chem
, vol.39
, pp. 2354-2366
-
-
O'Brien, P.M.1
Sliskovic, D.R.2
Picard, J.A.3
Lee, H.T.4
Purchase, C.F.5
Roth, B.D.6
White, A.D.7
-
65
-
-
10144229124
-
Heterocyclic amides: Inhibitors of ACAT with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit
-
White, A.D.; Purchase, C.F.; Picard, J.A.; Anderson, M.K.; Mueller, S.K. Heterocyclic amides: inhibitors of ACAT with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit. J. Med. Chem. 1996, 39, 3908-3919.
-
(1996)
J. Med. Chem
, vol.39
, pp. 3908-3919
-
-
White, A.D.1
Purchase, C.F.2
Picard, J.A.3
Anderson, M.K.4
Mueller, S.K.5
-
66
-
-
0028214973
-
Inhibitors of ACAT. Synthesis and hypocholesterolemic activity of Dibenz[b,e]oxepin-11-carboxamides
-
Kumazaya, T.; Yanase, M.; Harakawa, H.; Obase, H.; Shirakura, S. Inhibitors of ACAT. Synthesis and hypocholesterolemic activity of Dibenz[b,e]oxepin-11-carboxamides. J. Med. Chem. 1994, 37, 804-810.
-
(1994)
J. Med. Chem
, vol.37
, pp. 804-810
-
-
Kumazaya, T.1
Yanase, M.2
Harakawa, H.3
Obase, H.4
Shirakura, S.5
-
67
-
-
0029143099
-
Amides of piperidine, morpholine and piperazine substituted 1- phenylethylamines: Inhibitors of ACAT activity in vitro and in vivo
-
Dugar, S.; Davis, H.R.; Burrier, R.E.; Salisbury, B.G. Amides of piperidine, morpholine and piperazine substituted 1- phenylethylamines: inhibitors of ACAT activity in vitro and in vivo. Bioorg. Med. Chem. 1995, 3, 1231-1236.
-
(1995)
Bioorg. Med. Chem
, vol.3
, pp. 1231-1236
-
-
Dugar, S.1
Davis, H.R.2
Burrier, R.E.3
Salisbury, B.G.4
-
68
-
-
15844430993
-
Inhibitors of Acyl CoA-Cholesterol acyltransferase
-
Vaccaro, W; Amore, C.; Berger, J.; Burrier, R.; Davis, H.; Salisbury, B. Inhibitors of Acyl CoA-Cholesterol acyltransferase. J. Med. Chem. 1996, 39, 1704-1719.
-
(1996)
J. Med. Chem
, vol.39
, pp. 1704-1719
-
-
Vaccaro, W.1
Amore, C.2
Berger, J.3
Burrier, R.4
Davis, H.5
Salisbury, B.6
-
69
-
-
0029875106
-
Potent inhibitors of ACAT: SARs of novel N-(2,2-Dimethyl-2,3- dihydrobenzofuran-7-yl)amides
-
Kataoka, K.; Shiota, T.; Takeyasu, T.; Mochizuki, T.; Taneda, K. Potent inhibitors of ACAT: SARs of novel N-(2,2-Dimethyl-2,3- dihydrobenzofuran-7-yl)amides. J. Med. Chem. 1996, 39, 1262-1270.
-
(1996)
J. Med. Chem
, vol.39
, pp. 1262-1270
-
-
Kataoka, K.1
Shiota, T.2
Takeyasu, T.3
Mochizuki, T.4
Taneda, K.5
-
70
-
-
0034935946
-
SARs of N-(3,5- Dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl) piperazine and analogs as inhibitors of ACAT
-
Ohishi, K.; Aiama, R.; Hatano, H.; Yoshida, Y.; Wada, Y.; Wakae, Y.; Sawada, H.; Watanabe, T.; Yokokura, T. SARs of N-(3,5- Dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl) piperazine and analogs as inhibitors of ACAT. Chem. Pharm. Bull. 2001, 49, 830-839.
-
(2001)
Chem. Pharm. Bull
, vol.49
, pp. 830-839
-
-
Ohishi, K.1
Aiama, R.2
Hatano, H.3
Yoshida, Y.4
Wada, Y.5
Wakae, Y.6
Sawada, H.7
Watanabe, T.8
Yokokura, T.9
-
71
-
-
69249186403
-
Synthesis of a novel series of Imidazo[1,2-α]pyridines as ACAT inhibitors
-
Jin, Y.; Rho, M.; Gajulapati, K.; Jung, H.Y.; Boovanahalli, S.K.; Lee, J.H.; Song, G.; Choi, J.H.; Kim, Y.K.; Lee, K.; Choi, Y. Synthesis of a novel series of Imidazo[1,2-α]pyridines as ACAT inhibitors. Bull. Korean. Chem. Soc. 2009, 30, 1297-1304.
-
(2009)
Bull. Korean. Chem. Soc
, vol.30
, pp. 1297-1304
-
-
Jin, Y.1
Rho, M.2
Gajulapati, K.3
Jung, H.Y.4
Boovanahalli, S.K.5
Lee, J.H.6
Song, G.7
Choi, J.H.8
Kim, Y.K.9
Lee, K.10
Choi, Y.11
-
72
-
-
0036985469
-
ACAT inhibitors: The search for a novel and effective treatment of hypocholesterolemia and atherosclerosis
-
Sliskovic, D.R.; Picard, J.A.; Krause, B.R. ACAT inhibitors: The search for a novel and effective treatment of hypocholesterolemia and atherosclerosis. Prog. In Med. Chem. 2002, 39, 121-171.
-
(2002)
Prog. In Med. Chem
, vol.39
, pp. 121-171
-
-
Sliskovic, D.R.1
Picard, J.A.2
Krause, B.R.3
-
73
-
-
0020518669
-
Potential anti-atherosclerotic agents. 4.[(Functionalizedalkyl)amino]benzoic acid analogs of cetaben
-
De Vries, V.G.; Largis, E.E.; Miner, T.G.; Shepherd, R.G.; Upeslachis, J. Potential anti-atherosclerotic agents. 4.[(Functionalizedalkyl)amino]benzoic acid analogs of cetaben. J. Med. Chem. 1983, 26, 1411-1421.
-
(1983)
J. Med. Chem
, vol.26
, pp. 1411-1421
-
-
de Vries, V.G.1
Largis, E.E.2
Miner, T.G.3
Shepherd, R.G.4
Upeslachis, J.5
-
74
-
-
0027985805
-
ACAT inhibitors: Synthesis and SAR studies of a new series of trisubstituted imidazoles
-
Higley, C.A.; Wilde, R.G.; Maduskuie, T.P.; Johnson, A.L.; Pennev, P.; Billheimer, J.T.; Robinson, C.S. ACAT inhibitors: synthesis and SAR studies of a new series of trisubstituted imidazoles. J. Med. Chem. 1994, 37, 3511-3522.
-
(1994)
J. Med. Chem
, vol.37
, pp. 3511-3522
-
-
Higley, C.A.1
Wilde, R.G.2
Maduskuie, T.P.3
Johnson, A.L.4
Pennev, P.5
Billheimer, J.T.6
Robinson, C.S.7
-
75
-
-
0028821570
-
ACAT inhibitors: Ureas bearing two heterocyclic head groups
-
Wilde, R.G.; Billheimer, J.T. ACAT inhibitors: Ureas bearing two heterocyclic head groups. Bioorg. & Med. Chem. Lett. 1995, 5, 173-176.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 173-176
-
-
Wilde, R.G.1
Billheimer, J.T.2
-
76
-
-
0028817656
-
ACAT inhibitors: Heterocyclic bioisosteres for the urea group in DuP-128
-
Wilde, R.G.; Billheimer, J.T.; Klaczkiewicz, J.D.; Wexler, R.R. Gillies, P.J. ACAT inhibitors: Heterocyclic bioisosteres for the urea group in DuP-128. Bioorg. & Med. Chem. Lett. 1995, 5, 177-180.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 177-180
-
-
Wilde, R.G.1
Billheimer, J.T.2
Klaczkiewicz, J.D.3
Wexler, R.R.4
Gillies, P.J.5
-
77
-
-
0028817654
-
ACAT inhibitors: Ureas bearing heterocyclic groups bioisoosterc for an imidazole
-
Wilde, R.G.; Billheimer, J.T.; Germain, S.J.; Gillies, P.J.; Higley, C.A. ACAT inhibitors: Ureas bearing heterocyclic groups bioisoosterc for an imidazole. Bioorg. & Med. Chem. Lett. 1995, 5, 167-172.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 167-172
-
-
Wilde, R.G.1
Billheimer, J.T.2
Germain, S.J.3
Gillies, P.J.4
Higley, C.A.5
-
78
-
-
0030572490
-
Tetrazole substituted ureas as inhibitors of ACAT. A novel preparation of ureas from weakly nucleophilic amines
-
Purchase, C.F.; White, A.D.; Anderson, M.K.; Bocan, T.M.A.; Bousley, R.F.; Hamelehle, K.L.; Reindel, J.F. Tetrazole substituted ureas as inhibitors of ACAT. A novel preparation of ureas from weakly nucleophilic amines. Bioorg. & Med. Chem. Lett. 1996, 6, 1753-1758.
-
(1996)
Bioorg. & Med. Chem. Lett
, vol.6
, pp. 1753-1758
-
-
Purchase, C.F.1
White, A.D.2
Anderson, M.K.3
Bocan, T.M.A.4
Bousley, R.F.5
Hamelehle, K.L.6
Reindel, J.F.7
-
79
-
-
0030915341
-
Inhibitors of ACAT: Novel trisubstituted ureas as hypocholesterolemic agents
-
Purchase, T.S.; Essenburg, A.D.; Hamelehle, K.L.; Hes, M.S.; Holmes, A.; Krause, B.R.; Stanfield, R.L; Trivedi, B.K. Inhibitors of ACAT: novel trisubstituted ureas as hypocholesterolemic agents Bioorg. & Med. Chem. 1997, 5, 739-747.
-
(1997)
Bioorg & Med. Chem
, vol.5
, pp. 739-747
-
-
Purchase, T.S.1
Essenburg, A.D.2
Hamelehle, K.L.3
Hes, M.S.4
Holmes, A.5
Krause, B.R.6
Stanfield, R.L.7
Trivedi, B.K.8
-
80
-
-
0032488587
-
X-ray crystal structure, and biological activity o FR186054, a novel, potent, orally active inhibitor of ACAT bearing a pyrazole ring
-
Tanaka, A.; Terasawa, T.; Hagihara, H.; Kinoshita, T.; Sakuma, Y.; Ishibe, N.; Sawada, M.; Takasugi, H.; Tanaka, H. Synthesis, X-ray crystal structure, and biological activity o FR186054, a novel, potent, orally active inhibitor of ACAT bearing a pyrazole ring. Bioorg. & Med. Chem. Lett. 1998, 8, 81-86.
-
(1998)
Bioorg. & Med. Chem. Lett
, vol.8
, pp. 81-86
-
-
Tanaka, A.1
Terasawa, T.2
Hagihara, H.3
Kinoshita, T.4
Sakuma, Y.5
Ishibe, N.6
Sawada, M.7
Takasugi, H.8
Tanaka, H.S.9
-
81
-
-
0031976074
-
Inhibitors of ACAT Part 1: Identification and SARs of a novel series of substituted N-alkyl-N-biphenylmethyl-N'-arylureas
-
Tanaka, A.; Terasawa, T.; Hagihara, H.; Kinoshita, T.; Sakuma, Y.; Ishibe, N.; Sawada, M.; Takasugi, H.; Tanaka, H. Inhibitors of ACAT Part 1: Identification and SARs of a novel series of substituted N-alkyl-N-biphenylmethyl-N'-arylureas. Bioorg. & Med. Chem. 1998, 6, 15-30.
-
(1998)
Bioorg. & Med. Chem
, vol.6
, pp. 15-30
-
-
Tanaka, A.1
Terasawa, T.2
Hagihara, H.3
Kinoshita, T.4
Sakuma, Y.5
Ishibe, N.6
Sawada, M.7
Takasugi, H.8
Tanaka, H.9
-
82
-
-
0035033577
-
Novel hydroxyhenylurea dual inhibitor against ACAT and low density lipoprotein (LDL)oxidation as antiatherosclerotic agent
-
Nakao, K.; Kubota, H.; Yasuhara, M.; Saito, K.; Suzuki, T.; Ohmizu, H.; Shimizu, R. Novel hydroxyhenylurea dual inhibitor against ACAT and low density lipoprotein (LDL)oxidation as antiatherosclerotic agent. Bioorg. & Med. Chem. 2001, 9, 853-861.
-
(2001)
Bioorg. & Med. Chem
, vol.9
, pp. 853-861
-
-
Nakao, K.1
Kubota, H.2
Yasuhara, M.3
Saito, K.4
Suzuki, T.5
Ohmizu, H.6
Shimizu, R.7
-
83
-
-
0035935748
-
5,6- Diphenylpyridazine derivatives as ACAT inhibitor
-
Giovannoni, M.P.; Piaz, V. P.; Kwon, B.M.; Kim, M.K.; Kim, Y. K.; Toma, L.; Barlocco, D.; Bernini, F. Canavesi, M. 5,6- Diphenylpyridazine derivatives as ACAT inhibitor. J. Med. Chem. 2001, 44, 4292-4295.
-
(2001)
J. Med. Chem
, vol.44
, pp. 4292-4295
-
-
Giovannoni, M.P.1
Piaz, V.P.2
Kwon, B.M.3
Kim, M.K.4
Kim, Y.K.5
Toma, L.6
Barlocco, D.7
Bernini, F.8
Canavesi, M.9
-
84
-
-
28144457982
-
Mono- or Diphenylpyridazines connected to N-(2,4-Diflurophenyl)-N'-heptylureas as ACAT inhibitors
-
Gelain, A.; Bettinelli, I.; Barlocco, D.; Kwon, B.W.; Jeong, T. S.; Cho, K.H.; Toma, L. Mono- or Diphenylpyridazines connected to N-(2,4-Diflurophenyl)-N'-heptylureas as ACAT inhibitors. J. Med. Chem. 2005, 48, 7708-7713.
-
(2005)
J. Med. Chem
, vol.48
, pp. 7708-7713
-
-
Gelain, A.1
Bettinelli, I.2
Barlocco, D.3
Kwon, B.W.4
Jeong, T.S.5
Cho, K.H.6
Toma, L.7
-
85
-
-
33750689478
-
Ureidopyridazine derivatives as ACAT inhibitors
-
Gelain, A.; Bettinelli, I.; Barlocco, D.; Kwon, B.W.; Jeong, T.S.; Legani, L.; Toma, L. Ureidopyridazine derivatives as ACAT inhibitors. Sci. Pharm. 2006, 74, 85.
-
(2006)
Sci. Pharm
, vol.74
, pp. 85
-
-
Gelain, A.1
Bettinelli, I.2
Barlocco, D.3
Kwon, B.W.4
Jeong, T.S.5
Legani, L.6
Toma, L.7
-
86
-
-
0027156260
-
SAR of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of ACAT with Anti-atherosclerotic activity
-
Kimura, T.; Watanabe, N.; Matsui, M.; Hayashi, K.; Tanaka, H.; Ohtsuka, I.; Saeki, T.; Yamatsu, I. SAR of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of ACAT with Anti-atherosclerotic activity. J. Med. Chem. 1993, 36, 1641-1653.
-
(1993)
J. Med. Chem
, vol.36
, pp. 1641-1653
-
-
Kimura, T.1
Watanabe, N.2
Matsui, M.3
Hayashi, K.4
Tanaka, H.5
Ohtsuka, I.6
Saeki, T.7
Yamatsu, I.8
-
87
-
-
0027406430
-
Substituted N,N'-Diphenyl ureas as potent inhibitors of ACAT. B
-
Trivedi, B.K.; Stoeber, T.L.; Stanfield, R.L.; Hamelehle, K.L.; Krause, B.R. Substituted N,N'-Diphenyl ureas as potent inhibitors of ACAT. Bioorg. & Med. Chem. Lett. 1993, 3, 259-262.
-
(1993)
Ioorg. & Med. Chem. Lett
, vol.3
, pp. 259-262
-
-
Trivedi, B.K.1
Stoeber, T.L.2
Stanfield, R.L.3
Hamelehle, K.L.4
Krause, B.R.5
-
88
-
-
0028236806
-
Inhibitors of ACAT. 7. Development of a series of substituted Nphenyl- N'-[(1-phenylcyclopentl)methyl]ureas with enhanced hypocholesterolemic activity
-
Trivedi, B.K.; Purchase, T.S.; Holmes, A.; Augelli-Szafran, C.E.; Hamelehle, K.L.; Stanfield, R.L.; Bousley, R.F.; Krause, B.R. Inhibitors of ACAT. 7. Development of a series of substituted Nphenyl- N'-[(1-phenylcyclopentl)methyl]ureas with enhanced hypocholesterolemic activity. J. Med. Chem. 1994, 37, 1652-1659.
-
(1994)
J. Med. Chem
, vol.37
, pp. 1652-1659
-
-
Trivedi, B.K.1
Purchase, T.S.2
Holmes, A.3
Augelli-Szafran, C.E.4
Hamelehle, K.L.5
Stanfield, R.L.6
Bousley, R.F.7
Krause, B.R.8
-
89
-
-
77957183454
-
Subacute toxicity of a novel inhibitor of ACAT in beagle dogs
-
Dominick, M.A.; McGuire, E.J.; Reindel, J.F.; Bobrowski, W.F.; Bocan, T.M.A.; Gough, A.W. Subacute toxicity of a novel inhibitor of ACAT in beagle dogs. Fundam. Appl. Toxicol. 1993, 20, 217-224.
-
(1993)
Fundam. Appl. Toxicol
, vol.20
, pp. 217-224
-
-
Dominick, M.A.1
McGuire, E.J.2
Reindel, J.F.3
Bobrowski, W.F.4
Bocan, T.M.A.5
Gough, A.W.6
-
90
-
-
0027283726
-
Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD-132301-2, an inhibitor of ACAT
-
Dominick, M.A.; Bobrowski, W.F.; Mac Donald, J.R.; Gough, A.W. Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD-132301-2, an inhibitor of ACAT. Toxicol. Pathol. 1993, 21, 54-62.
-
(1993)
Toxicol. Pathol
, vol.21
, pp. 54-62
-
-
Dominick, M.A.1
Bobrowski, W.F.2
Donald, J.R.3
Gough, A.W.4
-
91
-
-
0028604422
-
Toxicologic effects of a novel ACAT inhibitor in cynomolgus monkeys
-
Reindel, J.F.; Dominick, M.A.; Bocan, T.M.A.; Gough, A.W.; McGuire, E.J. Toxicologic effects of a novel ACAT inhibitor in cynomolgus monkeys. Toxicol. Pathol. 1994, 22, 510-518.
-
(1994)
Toxicol. Pathol
, vol.22
, pp. 510-518
-
-
Reindel, J.F.1
Dominick, M.A.2
Bocan, T.M.A.3
Gough, A.W.4
McGuire, E.J.5
-
92
-
-
0028286581
-
Inhibitors of ACAT as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo
-
O'Brien, P.M.; Silskovic, D.R.; Blankley, C.J.; Roth, B.D.; Wilson, M.W.; Hamelehle, K. L.; Krause, B.R.; Stanfield, R.L. Inhibitors of ACAT as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo. J. Med. Chem. 1994, 37, 1810-1822.
-
(1994)
J. Med. Chem
, vol.37
, pp. 1810-1822
-
-
O'Brien, P.M.1
Silskovic, D.R.2
Blankley, C.J.3
Roth, B.D.4
Wilson, M.W.5
Hamelehle, K.L.6
Krause, B.R.7
Stanfield, R.L.8
-
93
-
-
0028865627
-
A series of conformationally and sterically constrained analogs of N-phenyl- N'-aralkylurea ACAT inhibitors
-
Trivedi, B.K.; Holmes, A.; Purchase, T.S.; Essenburg, A.D.; Hamelehle, K.L.; Krause, B. R.; Stanfield, R.L. A series of conformationally and sterically constrained analogs of N-phenyl- N'-aralkylurea ACAT inhibitors. Bioorg. & Med. Chem. Lett. 1995, 5, 2229-2234.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 2229-2234
-
-
Trivedi, B.K.1
Holmes, A.2
Purchase, T.S.3
Essenburg, A.D.4
Hamelehle, K.L.5
Krause, B.R.6
Stanfield, R.L.7
-
94
-
-
10244252718
-
Heterocyclic ureas: Inhibitors of ACAT as hypocholesterolemic agents
-
White, A.D.; Creswell, M.W.; Chucholowski, A.W.; Blankley, J.; Wilson, M.W.; Bousley, R.F.; Essenburg, A.D.; Hamelehle, K.L.; Krause, B.R.; Stanfield, R.L.; Dominick, M.A.; Neub, M. Heterocyclic ureas: Inhibitors of ACAT as hypocholesterolemic agents. J. Med. Chem. 1996, 39, 4382.
-
(1996)
J. Med. Chem
, vol.39
, pp. 4382
-
-
White, A.D.1
Creswell, M.W.2
Chucholowski, A.W.3
Blankley, J.4
Wilson, M.W.5
Bousley, R.F.6
Essenburg, A.D.7
Hamelehle, K.L.8
Krause, B.R.9
Stanfield, R.L.10
Dominick, M.A.11
Neub, M.12
-
95
-
-
0035004680
-
Pharmacolocgical properties of R-755, a novel ACAT inhibitor, in Cholesterol-fed rats, hamsters and rabbits
-
Matsui, Y.; Horiuchi, K.; Yamamoto, K.; Kanai, K. Pharmacolocgical properties of R-755, a novel ACAT inhibitor, in Cholesterol-fed rats, hamsters and rabbits. Jpn. J. Pharmacol. 2001, 85, 423-433.
-
(2001)
Jpn. J. Pharmacol
, vol.85
, pp. 423-433
-
-
Matsui, Y.1
Horiuchi, K.2
Yamamoto, K.3
Kanai, K.4
-
96
-
-
0029098950
-
N-(1-phenyl-2-benzimidazolyl)-N'-phenylurea derivatives as potent inhibitors of ACAT
-
Kumazawa, T.; Harakawa, H.; Fukui, H.; Shirakura, S.; Ohishi, E.; Yamada, K. N-(1-phenyl-2-benzimidazolyl)-N'-phenylurea derivatives as potent inhibitors of ACAT. Bioorg. & Med. Chem. Lett. 1995, 5, 1829-1832.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 1829-1832
-
-
Kumazawa, T.1
Harakawa, H.2
Fukui, H.3
Shirakura, S.4
Ohishi, E.5
Yamada, K.6
-
97
-
-
0028128921
-
Novel ACAT inhibitors. Synthesis and biological activity of 3-guinolylurea derivatives
-
Tawada, H.; Harcourt, M.; Kawamura, N.; Kajino, M.; Ishikawa, E.; Sugiyama, Y.; Ikeda, H.; Meguro, K. Novel ACAT inhibitors. Synthesis and biological activity of 3-guinolylurea derivatives. J. Med. Chem. 1994, 37, 2079-2084.
-
(1994)
J. Med. Chem
, vol.37
, pp. 2079-2084
-
-
Tawada, H.1
Harcourt, M.2
Kawamura, N.3
Kajino, M.4
Ishikawa, E.5
Sugiyama, Y.6
Ikeda, H.7
Meguro, K.8
-
98
-
-
1242293871
-
Synthesis and structure-activity relationship studies on a novel series of naphthylidonoylureas as inhibitors of ACAT
-
Ohnuma, S.; Muraoka, M.; Ioriya, K.; Ohashi, N. Synthesis and structure-activity relationship studies on a novel series of naphthylidonoylureas as inhibitors of ACAT. Bioorg. & Med. Chem. Lett. 2004, 14, 1309-1311.
-
(2004)
Bioorg. & Med. Chem. Lett
, vol.14
, pp. 1309-1311
-
-
Ohnuma, S.1
Muraoka, M.2
Ioriya, K.3
Ohashi, N.4
-
99
-
-
24944561845
-
Synthesis of SMP-797: A new potent ACAT inhibitor
-
Ban, H.; Muraoka, M.; Ohashi, N. Synthesis of SMP-797: a new potent ACAT inhibitor. Tetrahedron. 2005, 61, 10081-10092.
-
(2005)
Tetrahedron
, vol.61
, pp. 10081-10092
-
-
Ban, H.1
Muraoka, M.2
Ohashi, N.3
-
100
-
-
59649104957
-
Novel 1,4- diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: Dual effectors on ACAT and low-density lipoprotein receptor expression
-
Asano, S.; Ban, H.; Kino, K.; Ioriya, K.; Maraoka, M. Novel 1,4- diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on ACAT and low-density lipoprotein receptor expression. Bioorg. & Med. Chem. Lett. 2009, 19, 1062-1065.
-
(2009)
Bioorg. & Med. Chem. Lett
, vol.19
, pp. 1062-1065
-
-
Asano, S.1
Ban, H.2
Kino, K.3
Ioriya, K.4
Maraoka, M.5
-
101
-
-
66449122310
-
Synthesis and SARs of N-(4-amino-2,6-diisopropyl-phenyl)-N'- (1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents
-
Asano, S.; Ban, H.; Kino, K.; Ioriya, K.; Maraoka, M. Synthesis and SARs of N-(4-amino-2,6-diisopropyl-phenyl)-N'- (1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents. Bioorg. & Med. Chem. 2009, 17, 4636-4646.
-
(2009)
Bioorg. & Med. Chem
, vol.17
, pp. 4636-4646
-
-
Asano, S.1
Ban, H.2
Kino, K.3
Ioriya, K.4
Maraoka, M.5
-
102
-
-
0028214744
-
Inhibitor of ACAT as hypocholesterolemic agents. 6. The first water soluble ACAT inhibitor with lipid-regulating activity
-
Silskovic, D.R.; Krause, B.R.; Picard, J.; Anderson, M.; Bousley, R.F.; Hamlehle, K.L.; Homan, R.; Julian, T.N.; Rashidbagi, Z.A.; Stanfield, R.L. Inhibitor of ACAT as hypocholesterolemic agents. 6. The first water soluble ACAT inhibitor with lipid-regulating activity. J. Med. Chem. 1994, 37, 560-562.
-
(1994)
J. Med. Chem
, vol.37
, pp. 560-562
-
-
Silskovic, D.R.1
Krause, B.R.2
Picard, J.3
Anderson, M.4
Bousley, R.F.5
Hamlehle, K.L.6
Homan, R.7
Julian, T.N.8
Rashidbagi, Z.A.9
Stanfield, R.L.10
-
103
-
-
77957178035
-
Hepatic and adrenal toxicity of a novel lipid regulator in beagle dogs
-
Wolfgang, G.H.I.; Robertson, D.G.; Welty, D.F.; Metz, A.L. Hepatic and adrenal toxicity of a novel lipid regulator in beagle dogs. Fundam. Appl. Toxicol. 1995, 26, 272-281.
-
(1995)
Fundam. Appl. Toxicol
, vol.26
, pp. 272-281
-
-
Wolfgang, G.H.I.1
Robertson, D.G.2
Welty, D.F.3
Metz, A.L.4
-
104
-
-
0028828549
-
Inhibitors of ACAT. 15. Sulfonylurea inhibitors with excellent hypocholesterolemic activity in vivo
-
Roth, B.D.; Roark, W.H.; Sliskovic, D.R.; Krause, B.R.; Picard, J.; Anderson, M.; Bousley, R.F.; Hamlehle, K.L.; Homan, R.; Julian, T.N.; Stanfield, R.L. Inhibitors of ACAT. 15. Sulfonylurea inhibitors with excellent hypocholesterolemic activity in vivo. Bioorg. & Med. Chem. Lett. 1995, 5, 2367-2370.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 2367-2370
-
-
Roth, B.D.1
Roark, W.H.2
Sliskovic, D.R.3
Krause, B.R.4
Picard, J.5
Anderson, M.6
Bousley, R.F.7
Hamlehle, K.L.8
Homan, R.9
Julian, T.N.10
Stanfield, R.L.11
-
105
-
-
0028819251
-
Inhibitors of ACAT as hypocholesterolemic agents. 14. Synthesis and SARs of a novel series of sulphonamide tetrazoles
-
Lee, H.T.; Sliskovic, D.R.; Stanfield, R.L.; Hamlehle, K.L.; Bousley, R.F.; Krause, B.R. Inhibitors of ACAT as hypocholesterolemic agents. 14. Synthesis and SARs of a novel series of sulphonamide tetrazoles. Bioorg. & Med. Chem. Lett. 1995, 5, 301-306.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 301-306
-
-
Lee, H.T.1
Sliskovic, D.R.2
Stanfield, R.L.3
Hamlehle, K.L.4
Bousley, R.F.5
Krause, B.R.6
-
106
-
-
0029892115
-
Inhibitors of ACAT. 17. SARs of several series of compounds derived from N-Chlorosulfonyl isocyanate
-
Picard, J.A.; O'Brien, P.M.; Sliskovic, D.R.; Krause, B.R.; Anderson, M.; Bousley, R.F.; Hamlehle, K.L.; Stanfield, R.L. Inhibitors of ACAT. 17. SARs of several series of compounds derived from N-Chlorosulfonyl isocyanate. J. Med. Chem. 1996, 39, 1243-1252.
-
(1996)
J. Med. Chem
, vol.39
, pp. 1243-1252
-
-
Picard, J.A.1
O'Brien, P.M.2
Sliskovic, D.R.3
Krause, B.R.4
Anderson, M.5
Bousley, R.F.6
Hamlehle, K.L.7
Stanfield, R.L.8
-
107
-
-
0030472785
-
Inhibitors of ACAT as hypocholesterolemic agents. CI-1011: An acyl sulfamate with unique Cholesterol-lowering activity in aminals fed noncholesterolsupplemented diets
-
Lee, H.T.; Sliskovic, D. R.; Stanfield, R. L.; Hamlehle, K. L.; Bousley, R. F.; Krause, B. R. Inhibitors of ACAT as hypocholesterolemic agents. CI-1011: An acyl sulfamate with unique Cholesterol-lowering activity in aminals fed noncholesterolsupplemented diets. J. Med. Chem. 1996, 39, 5031-5034.
-
(1996)
J. Med. Chem
, vol.39
, pp. 5031-5034
-
-
Lee, H.T.1
Sliskovic, D.R.2
Stanfield, R.L.3
Hamlehle, K.L.4
Bousley, R.F.5
Krause, B.R.6
-
108
-
-
0032477856
-
Inhibitors of ACAT as hypocholesterolemic agents: Synthesis and SARs of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates
-
Lee, H.T.; Roark, W.H.; Sliskovic, D.R.; Stanfield, R.L.; Hamlehle, K.L.; Bousley, R.F.; Krause, B.R. Inhibitors of ACAT as hypocholesterolemic agents: Synthesis and SARs of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates. Bioorg. & Med. Chem. Lett. 1998, 8, 289-294.
-
(1998)
Bioorg. & Med. Chem. Lett
, vol.8
, pp. 289-294
-
-
Lee, H.T.1
Roark, W.H.2
Sliskovic, D.R.3
Stanfield, R.L.4
Hamlehle, K.L.5
Bousley, R.F.6
Krause, B.R.7
-
109
-
-
49449088714
-
Novel indoline-based ACAT inhibitor with anitperoxidative activity: Improvement of physicochemical properties and biological activities by introduction of carboxylic acid
-
Takahashi, K.; Shoji, Y.; Ohta, M.; Kasai, M.; Kunishiro, K.; Kanda, M.; Yogai, S.; Takeuchi, Y.; Shirahase, H. Novel indoline-based ACAT inhibitor with anitperoxidative activity: Improvement of physicochemical properties and biological activities by introduction of carboxylic acid. J. Med. Chem. 2008, 51, 4823-4833.
-
(2008)
J. Med. Chem
, vol.51
, pp. 4823-4833
-
-
Takahashi, K.1
Shoji, Y.2
Ohta, M.3
Kasai, M.4
Kunishiro, K.5
Kanda, M.6
Yogai, S.7
Takeuchi, Y.8
Shirahase, H.9
-
110
-
-
68149110226
-
Novel indoline based ACAT inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities
-
Shoji, Y.; Takahashi, K.; Ohta, M.; Kasai, M.; Kunishiro, K.; Kanda, M.; Yogai, S.; Takeuchi, Y.; Shirahase, H. Novel indoline based ACAT inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities. Bioorg. Med. Chem. 2009, 17, 6020-6031.
-
(2009)
Bioorg. Med. Chem
, vol.17
, pp. 6020-6031
-
-
Shoji, Y.1
Takahashi, K.2
Ohta, M.3
Kasai, M.4
Kunishiro, K.5
Kanda, M.6
Yogai, S.7
Takeuchi, Y.8
Shirahase, H.9
-
111
-
-
77951133543
-
A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia
-
Asano, S.; Ban, H.; Tsuboya, N.; Uno, S.; Kino, K.; Ioriya, K.; Kitano, M.; Ueno, Y. A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia. J. Med. Chem. 2010, 53, 3284-3295.
-
(2010)
J. Med. Chem
, vol.53
, pp. 3284-3295
-
-
Asano, S.1
Ban, H.2
Tsuboya, N.3
Uno, S.4
Kino, K.5
Ioriya, K.6
Kitano, M.7
Ueno, Y.8
-
112
-
-
77952101896
-
First identification of xanthone sulphonamides as potent ACAT inhibitors
-
Hua, H.; Liao, H.; Zhang, J.; Wua, W.; Yan, J.; Yan, Y.; Zhao, Q.; Zou, Y.; Chai, X.; Yu, S.; Wu, Q. First identification of xanthone sulphonamides as potent ACAT inhibitors. Bioorg. & Med. Chem. Lett. 2010, 20, 3094-3098.
-
(2010)
Bioorg. & Med. Chem. Lett
, vol.20
, pp. 3094-3098
-
-
Hua, H.1
Liao, H.2
Zhang, J.3
Wua, W.4
Yan, J.5
Yan, Y.6
Zhao, Q.7
Zou, Y.8
Chai, X.9
Yu, S.10
Wu, Q.11
-
113
-
-
0030593666
-
Singlet oxygen oxidation of pyrroles: Synthesis and chemical transformation of novel 4,4-bis(trifluoromethyl)imidazoline analogs
-
Li, H.; Drummond, S.; DeLucca, I.; Boswell, G.A. Singlet oxygen oxidation of pyrroles: Synthesis and chemical transformation of novel 4,4-bis(trifluoromethyl)imidazoline analogs. Tetrahedron. 1996, 52, 11153-11162.
-
(1996)
Tetrahedron
, vol.52
, pp. 11153-11162
-
-
Li, H.1
Drummond, S.2
Delucca, I.3
Boswell, G.A.4
-
114
-
-
0030935545
-
Asymmetric synthesis and absolute stereochemistry of 4,4-bis-(trifluoromethyl) imidazoline based ACAT inhibitors
-
Li, H.; Drummond, S.; DeLucca, I.; Boswell, G.A. Asymmetric synthesis and absolute stereochemistry of 4,4-bis-(trifluoromethyl) imidazoline based ACAT inhibitors. Tetrahedron. 1997, 53, 5359-5372.
-
(1997)
Tetrahedron
, vol.53
, pp. 5359-5372
-
-
Li, H.1
Drummond, S.2
Delucca, I.3
Boswell, G.A.4
-
115
-
-
0026474969
-
New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305
-
Tomoda, H.; Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305. J. Antibiot. 1992, 45, 1207-1215.
-
(1992)
J. Antibiot
, vol.45
, pp. 1207-1215
-
-
Tomoda, H.1
Nishida, H.2
Masuma, R.3
Cao, J.4
Okuda, S.5
Omura, S.6
-
116
-
-
0026498516
-
Inhibition of ACAT activity by cyclodepsipeptide antibiotics
-
Tomoda, H.; Huang, X.H.; Cao, J. Inhibition of ACAT activity by cyclodepsipeptide antibiotics. J. Antibiot. 1992, 45, 1626-1632.
-
(1992)
J. Antibiot
, vol.45
, pp. 1626-1632
-
-
Tomoda, H.1
Huang, X.H.2
Cao, J.3
-
117
-
-
0026030197
-
Purpactins, a new inhibitors of ACAT produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties
-
Tomoda, H.; Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. Purpactins, a new inhibitors of ACAT produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties. J. Antibiot. 1991, 44, 136-143.
-
(1991)
J. Antibiot
, vol.44
, pp. 136-143
-
-
Tomoda, H.1
Nishida, H.2
Masuma, R.3
Cao, J.4
Okuda, S.5
Omura, S.6
-
118
-
-
84892437652
-
New verticillin and Glisoprenin analoues from gliocladium c atenulatum, a mycoparasite of Aspergilus flavus sclerotia
-
Tomoda, H.; Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. New verticillin and Glisoprenin analoues from gliocladium c atenulatum, a mycoparasite of Aspergilus flavus sclerotia. J. Antibiot. 1993, 45, 1202-1206.
-
(1993)
J. Antibiot
, vol.45
, pp. 1202-1206
-
-
Tomoda, H.1
Nishida, H.2
Masuma, R.3
Cao, J.4
Okuda, S.5
Omura, S.6
-
119
-
-
0026540163
-
Glisoprenins, a new inhibitors of ACAT produced by Gliocladium sp. FO-1513.II. Structure elucidation o glisoprenins A & B
-
Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. Glisoprenins, a new inhibitors of ACAT produced by Gliocladium sp. FO-1513.II. Structure elucidation o glisoprenins A & B. J. Antibiot. 1992, 45, 1669-1676.
-
(1992)
J. Antibiot
, vol.45
, pp. 1669-1676
-
-
Nishida, H.1
Masuma, R.2
Cao, J.3
Okuda, S.4
Omura, S.5
-
120
-
-
0027259454
-
GERI-BP001, a new inhibitor of ACAT produced by Aspergillus fumigates F37
-
Kiroda, K.; Yoshida, M.; Vosaic, Y. GERI-BP001, a new inhibitor of ACAT produced by Aspergillus fumigates F37. J. Antibiot. 1993, 46, 1196-1202.
-
(1993)
J. Antibiot
, vol.46
, pp. 1196-1202
-
-
Kiroda, K.1
Yoshida, M.2
Vosaic, Y.3
-
121
-
-
0028829655
-
Chemical modification and SARs of pyripyropenes; potent, bioavailable inhibitor of ACAT
-
Obata, R.; Sunazuka, T.; Tomoda, H.; Harigaya, Y.; Omura, S. Chemical modification and SARs of pyripyropenes; potent, bioavailable inhibitor of ACAT. Bioorg. & Med. Chem. Lett. 1995, 5, 2683-2688.
-
(1995)
Bioorg. & Med. Chem. Lett
, vol.5
, pp. 2683-2688
-
-
Obata, R.1
Sunazuka, T.2
Tomoda, H.3
Harigaya, Y.4
Omura, S.5
-
122
-
-
0033577688
-
ACAT inhibitory activity of ginseng sapogenins, produced from the ginseng saponins
-
Kwon, B.M.; Kim, M.; Baek, N.; Kim, D.; Park, J.; Kim, Y.; Lee, H.; Kim, S. ACAT inhibitory activity of ginseng sapogenins, produced from the ginseng saponins. Bioorg. & Med. Chem. Lett. 1999, 9, 1375-1378.
-
(1999)
Bioorg. & Med. Chem. Lett
, vol.9
, pp. 1375-1378
-
-
Kwon, B.M.1
Kim, M.2
Baek, N.3
Kim, D.4
Park, J.5
Kim, Y.6
Lee, H.7
Kim, S.8
-
123
-
-
0033584147
-
Polyunsaturated fatty acid anilides as inhibitors of ACAT
-
Matsuyama M.; Kosaka, T.; Fukuhara, M.; Soda, Y.; Mizuno, K. Polyunsaturated fatty acid anilides as inhibitors of ACAT. Bioorg. & Med. Chem. Lett. 1999, 9, 2039-2042.
-
(1999)
Bioorg. & Med. Chem. Lett
, vol.9
, pp. 2039-2042
-
-
Matsuyama, M.1
Kosaka, T.2
Fukuhara, M.3
Soda, Y.4
Mizuno, K.5
-
124
-
-
2442541099
-
Human ACAT-1 and -2 inhibitory activities of Saucernol B, manassantin A and B isolated from Saururus chinensis
-
Lee, W.S.; Jeong, T.; Kim, K.S.; Yu, H.; Kim, M.J.; Cho, K.; Choi, Y.; Chin kim, H.; Park, H.; Lee, W. Human ACAT-1 and -2 inhibitory activities of Saucernol B, manassantin A and B isolated from Saururus chinensis. Bioorg. & Med. Chem. Lett. 2004, 14, 3109-3112.
-
(2004)
Bioorg. & Med. Chem. Lett
, vol.14
, pp. 3109-3112
-
-
Lee, W.S.1
Jeong, T.2
Kim, K.S.3
Yu, H.4
Kim, M.J.5
Cho, K.6
Choi, Y.7
Chin, K.H.8
Park, H.9
Lee, W.10
-
125
-
-
3142685202
-
-
Xu, M.; Lee, W.; Kim, M.J.; Park, D.; Yu, H.; Tian, G.; Jeong, T.; Park, H. ACAT inhibitory activities of fatty acid amides isolated from Mylabris phalerate pallas. Bioorg. & Med. Chem. Lett. 2004, 14, 4277-4280.
-
(2004)
ACAT Inhibitory Activities of Fatty Acid Amides Isolated From Mylabris Phalerate Pallas
, vol.14
, pp. 4277-4280
-
-
Xu, M.1
Lee, W.2
Kim, M.J.3
Park, D.4
Yu, H.5
Tian, G.6
Jeong, T.7
Park, H.8
-
126
-
-
33846568869
-
Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorizon
-
An, S.; Park, Y.; Paik, Y. Jeong, T.; Lee, W. Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorizon. Bioorg. & Med. Chem. Lett. 2007, 17, 1112-1116.
-
(2007)
Bioorg. & Med. Chem. Lett
, vol.17
, pp. 1112-1116
-
-
An, S.1
Park, Y.2
Paik, Y.3
Jeong, T.4
Lee, W.5
-
127
-
-
57349143965
-
inhibitory effects of flavonoisa deom Sophora flavescens
-
Jeong, T.; An, S.; Ryu, Y.; Kim, Y.; Cho, M.; Park, J.; Park, K.; Lee, W. Human ACAT inhibitory effects of flavonoisa deom Sophora flavescens. Bull. Korean. Chem. Soc. 2008, 29, 2287-2292.
-
(2008)
Bull. Korean. Chem. Soc
, vol.29
, pp. 2287-2292
-
-
Jeong, T.1
An, S.2
Ryu, Y.3
Kim, Y.4
Cho, M.5
Park, J.6
Park, K.7
Lee, W.8
Human, A.C.A.T.9
-
128
-
-
33847420834
-
ACAT inhibition of alkamides identified in the fruits of Piper nigrum
-
Rho, M.; Lee, S.W.; Park, H.R.; Choi, J.; Kang, J.Y.; Kim, K.; Lee, H.S.; Kim, Y.K. ACAT inhibition of alkamides identified in the fruits of Piper nigrum. Photochemistry. 2007, 68, 899-903.
-
(2007)
Photochemistry
, vol.68
, pp. 899-903
-
-
Rho, M.1
Lee, S.W.2
Park, H.R.3
Choi, J.4
Kang, J.Y.5
Kim, K.6
Lee, H.S.7
Kim, Y.K.8
-
129
-
-
0024989838
-
Antiatherosclerotic agents. A structurally novel bivalent inhibitor of ACAT with systemic activity
-
Gammill, R.B.; Bell, F.P.; Bell, L.T.; Bisaha, S.N.; Wilson, G.J. Antiatherosclerotic agents. A structurally novel bivalent inhibitor of ACAT with systemic activity. J. Med. Chem. 1990, 33, 2685-2687.
-
(1990)
J. Med. Chem
, vol.33
, pp. 2685-2687
-
-
Gammill, R.B.1
Bell, F.P.2
Bell, L.T.3
Bisaha, S.N.4
Wilson, G.J.5
-
130
-
-
80053425950
-
Discovery of a Potent and Orally Available Acyl- CoA: Cholesterol Acyltransferase Inhibitor as an Anti atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives
-
Ogino, M.; Fukui, S.; Nakada, Y.; Tokunoh, R.; Itokawa, S.; Kakoi, Y.; Nishimura, S.; Sanada, T.; Fuse, H.; Kubo, K.; Wada, T.; Marui, S. Discovery of a Potent and Orally Available Acyl- CoA: Cholesterol Acyltransferase Inhibitor as an Anti atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives. Chem. Pharm. Bull. 2011,59, 1268-1273.
-
(2011)
Chem. Pharm. Bull
, vol.59
, pp. 1268-1273
-
-
Ogino, M.1
Fukui, S.2
Nakada, Y.3
Tokunoh, R.4
Itokawa, S.5
Kakoi, Y.6
Nishimura, S.7
Sanada, T.8
Fuse, H.9
Kubo, K.10
Wada, T.11
Marui, S.12
-
131
-
-
81455155750
-
Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety
-
Ogino, M.; Nakada, Y.; Negoro, N.; Itokawa, S.; Nishimura, S.; Sanada, T.; Satomi, T.; Kita, S.; Kubo, K.; Marui, S. Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety. Chem. Pharm. Bull. 2011, 59, 1369-1375.
-
(2011)
Chem. Pharm. Bull
, vol.59
, pp. 1369-1375
-
-
Ogino, M.1
Nakada, Y.2
Negoro, N.3
Itokawa, S.4
Nishimura, S.5
Sanada, T.6
Satomi, T.7
Kita, S.8
Kubo, K.9
Marui, S.10
-
132
-
-
0025734242
-
Synthesis and hypocholesterolemic activity of 6,7- dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, a novel inhibitors of ACAT
-
Larsen, S.D.; Spilman, C.H.; Bell, F.P.; Dinh, D.M.; Martinborough, E.; Wilson, G.J. Synthesis and hypocholesterolemic activity of 6,7- dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, a novel inhibitors of ACAT. J. Med. Chem. 1991, 34, 1721-1727.
-
(1991)
J. Med. Chem
, vol.34
, pp. 1721-1727
-
-
Larsen, S.D.1
Spilman, C.H.2
Bell, F.P.3
Dinh, D.M.4
Martinborough, E.5
Wilson, G.J.6
-
133
-
-
0026714607
-
RP 70676: A potent systematically available inhibitor of ACAT
-
Ashton, M.J.; Bridge, A.W.; Bush, R.C.; Dron, D.I.; Harris, N.V.; Jones, G.D.; Lythgoe, D.J.; Riddell, D.; Smith, C. RP 70676: A potent systematically available inhibitor of ACAT. Bioorg. & Med. Chem. Lett. 1992, 2, 375-380.
-
(1992)
Bioorg. & Med. Chem. Lett
, vol.2
, pp. 375-380
-
-
Ashton, M.J.1
Bridge, A.W.2
Bush, R.C.3
Dron, D.I.4
Harris, N.V.5
Jones, G.D.6
Lythgoe, D.J.7
Riddell, D.8
Smith, C.9
-
134
-
-
0030021607
-
RP 73163: A bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor
-
Smith, C.; Ashton, M.J.; Harris, N.V.; Bush, R.C.; Facchini, V.; Jordan, R.; Mckenzie, R.; Riddell, D. RP 73163: A bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor. Bioorg. & Med. Chem. Lett. 1996, 6, 47-50.
-
(1996)
Bioorg. & Med. Chem. Lett
, vol.6
, pp. 47-50
-
-
Smith, C.1
Ashton, M.J.2
Harris, N.V.3
Bush, R.C.4
Facchini, V.5
Jordan, R.6
McKenzie, R.7
Riddell, D.8
-
135
-
-
70349730363
-
2- Substituted Thio- and amino-5,6-dimethoxy-1,4-naphthoquinones as a novel class of ACAT inhibitors
-
Shen, G.; Choi, J.H.; Gajulapati, K.; Lee, J.H.; Kim, Y. K.; Rho, M. C.; Jung, S.; Lee, K.; Han, S.S.; Song, G.; Choi, Y. 2- Substituted Thio- and amino-5,6-dimethoxy-1,4-naphthoquinones as a novel class of ACAT inhibitors. Bull. Korean. Chem. Soc. 2009, 30, 1088-1092.
-
(2009)
Bull. Korean. Chem. Soc
, vol.30
, pp. 1088-1092
-
-
Shen, G.1
Choi, J.H.2
Gajulapati, K.3
Lee, J.H.4
Kim, Y.K.5
Rho, M.C.6
Jung, S.7
Lee, K.8
Han, S.S.9
Song, G.10
Choi, Y.11
-
136
-
-
77955363537
-
Novel Tetrahydroisoquinoline Derivatives With Inhibitory Activities Against Acyl-Coa: Cholesterol Acyltransferase And Lipid Peroxidation
-
Ohta, M.; Takahashi, K.; Kasai, M.; Shoji, Y.; Kunishiro, K.; Miike, T.; Kanda, M.; Mukai, C.; Shirahase, H. Novel Tetrahydroisoquinoline Derivatives With Inhibitory Activities Against Acyl-Coa: Cholesterol Acyltransferase And Lipid Peroxidation. Chem. Pharm. Bull. 2010, 58, 1066-1076.
-
(2010)
Chem. Pharm. Bull
, vol.58
, pp. 1066-1076
-
-
Ohta, M.1
Takahashi, K.2
Kasai, M.3
Shoji, Y.4
Kunishiro, K.5
Miike, T.6
Kanda, M.7
Mukai, C.8
Shirahase, H.9
-
137
-
-
84862149887
-
Discovery of novel ACAT inhibitors: Pharmacophorebased virtual screening, synthesis and pharmacology
-
Chhabria, M.T.; Brahmkshatriya, P.S.; Mahajan, B.M.; Darji, U.B.; Shah, G.B. Discovery of novel ACAT inhibitors: Pharmacophorebased virtual screening, synthesis and pharmacology. Chem. Biol. Drug. Des. 2012, 80, 106-113.
-
(2012)
Chem. Biol. Drug. Des
, vol.80
, pp. 106-113
-
-
Chhabria, M.T.1
Brahmkshatriya, P.S.2
Mahajan, B.M.3
Darji, U.B.4
Shah, G.B.5
-
138
-
-
0037877207
-
Inhibition of ACAT: A possible treatment of atherosclerosis
-
Heinonen, T.M. Inhibition of ACAT: A possible treatment of atherosclerosis? Curr. Atherosclerosis Reports. 2002, 4, 65-70.
-
(2002)
Curr. Atherosclerosis Reports
, vol.4
, pp. 65-70
-
-
Heinonen, T.M.1
-
139
-
-
0037255303
-
Pharmacology of the ACAT inhibitor Avasimibe (CI-1011)
-
Llaverias, G.; Laguna, J.C.; Alegret, M. Pharmacology of the ACAT inhibitor Avasimibe (CI-1011). Cardiovascular Drug Reviews. 2003, 21, 33-50.
-
(2003)
Cardiovascular Drug Reviews
, vol.21
, pp. 33-50
-
-
Llaverias, G.1
Laguna, J.C.2
Alegret, M.3
-
140
-
-
40449110086
-
ACAT as a drug target for Alzheimer's disease
-
Huttunen, H.J.; Kovacs, D.M. ACAT as a drug target for Alzheimer's disease. Neurodegener Dis. 2008, 5, 212-214.
-
(2008)
Neurodegener Dis
, vol.5
, pp. 212-214
-
-
Huttunen, H.J.1
Kovacs, D.M.2
-
141
-
-
0034795651
-
ACAT enzyme modulates the generation of the amyloid β-peptide
-
Puglielli, L.; Konopka, G.; Pack-Chung, E.; MacKenzie Inago, L.A.; Berezovska, O.; Hyman, B.; Chang, T.Y.; Tanzi, R.E.; Kovacs, D.M. ACAT enzyme modulates the generation of the amyloid β-peptide. Nature Cell Biol. 2001, 3, 905-91.
-
(2001)
Nature Cell Biol
, vol.3
, pp. 905-991
-
-
Puglielli, L.1
Konopka, G.2
Pack-Chung, E.3
MacKenzie, I.L.A.4
Berezovska, O.5
Hyman, B.6
Chang, T.Y.7
Tanzi, R.E.8
Kovacs, D.M.9
|